Abstract
The synthesis and biological evaluation of a library of thirty differently substituted pyrazolo[3,4-b]pyridines bearing benzenesulfonamide moiety at position-1 and trifluoromethyl group at position-4 are reported. Fused heterocyclic system present in the target compounds (5a–j, 6a–j, and 7a–j) was constructed by refluxing various 5-aminopyrazoles (3a–c) with differently substituted trifluoromethyl-β-diketones (4a–j) in glacial acetic acid. All the target compounds (5–7) were evaluated for their in vitro antibacterial activity against four pathogenic bacterial strains namely, Staphylococcus aureus, Bacillus subtilis (Gram-positive), Escherichia coli, Pseudomonas aeruginosa (Gram-negative) and in vitro antifungal activity against two pathogenic fungal yeasts namely, Saccharomyces cerevisiae and Candida albicans.
Graphical Abstract
Thirty differently substituted pyrazolo[3,4-b]pyridines bearing benzenesulfonamide moiety at position-1 and trifluoromethyl group at position-4 were synthesized and screened for antibacterial and antifungal activities.
Similar content being viewed by others
References
Aggarwal R, Kumar V, Bansal A, Sanz D, Claramunt RM (2012) Multi-component solvent-free versus stepwise solvent mediated reactions: regiosepecific formation of 6-trifluoromethyl and 4-trifluoromethyl-1H-pyrazolo[3,4-b]pyridines. J Fluorine Chem 140:31–37
Ahlström MM, Ridderström M, Zamora I, Luthman K (2007) CYP2C9 structure–metabolism relationships: optimizing the metabolic stability of COX-2 inhibitors. J Med Chem 50:4444–4452
Ahmad I, Beg AJ (2001) Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. J Ethnopharmacol 74:13–123
Al-Said MS, Ghorab MM, Al-Dosari MS, Hamed MM (2011) Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety. Eur J Med Chem 46:201–207
Andrews JM (2001) determination of minimum inhibitory concentrations. Antimicrob Chemother 48:5–16
Bare TM, McLarem CD, Campbell DJB, Firor JW, Resch JF, Walters CP, Salama AI, Meiners BA, Patel JB (1989) Synthesis and structure-activity relationships of a series of anxioselective pyrazolopyridine ester and amide anxiolytic agents. J Med Chem 32:2561–2573
Basanagouda M, Shivashankar K, Kulkarni MV, Rasal VKP, Patel H, Mutha SS, Mohite AA (2010) Synthesis and antimicrobial studies on novel sulfonamides containing 4-azidomethyl coumarin. Eur J Med Chem 45:1151–1157
Bernardino AMR, Azevedo AR, Pinheiro LCS, Borges JCV, Carvalho L, Miranda MD, Meneses MDF, Nascimento M, Ferreira D, Rebello MA, Silva VAGG, Frugulhetti ICPP (2007) Synthesis and antiviral activity of new 4-(phenylamino)/4-[(methylpyridin-2-yl)amino]-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acids derivatives. Med Chem Res 16:352–369
Bharate SBT, Mahajan R, Gole YR, Nambiar M, Matan TT, Kulkarni-Almeida A, Balachandran S, Junjappa H, Balakrishnan A, Vishwakarma RA (2008) Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-α and IL-6 inhibitors. Bioorg Med Chem Lett 16:7167–7176
Blass B (2012) Fused heterocyclic compounds as ion channel modulators patent highlight. ACS Med Chem Lett 3:616–617
Chandak N, Kumar P, Sharma C, Aneja KR, Sharma PK (2012) Synthesis and biological evaluation of some novel thiazolylhydrazinomethylideneferrocenes as antimicrobial agents. Lett Drug Des Discov 9:63–68
Chandak N, Bhardwaj JK, Sharma RK, Sharma PK (2013) Inhibitors of apoptosis in testicular germ cells: synthesis and biological evaluation of some novel IBTs bearing sulfonamide moiety. Eur J Med Chem 59:203–208
Chen JJ, Li KT, Yang DY (2011) Synthesis of coumarin/phenanthridine-fused heterocycles and their photochemical and thermochromic properties. Org Lett 13:1658–1661
de Mello H, Echevarria A, Bernardino AM, Canto-Cavalheiro M, Leon LL (2004) Antileishmanial pyrazolopyridine derivatives: synthesis and structure-activity relationship analysis. J Med Chem 47:5427–5432
Dias LRS, Santos MB, de Albuquerque S, Castro HC, de Souza AMT, Freitas ACC, DiVaio MAV, Cabral LM, Rodrigues CR (2007) Synthesis, in vitro evaluation, and SAR studies of a potential antichagasic 1H-pyrazolo[3,4-b]pyridine series. Bioorg Med Chem 15:211–219
El-Sayad AT (2009) Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 6,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents. Eur J Med Chem 44:4385–4392
Emelina EE, Petrov AA, Selivanov SI, Filyukov DV (2008) α-Aminoazoles in synthesis of heterocycles. Part 3. 4-trifluoromethylpyrazolo[3,4-b]pyridines: synthesis and structure. Russ J Org Chem 44:251–256
Foks H, Pancechowska-Ksepko D, Kędzia A, Zwolska Z, Janowiec M, Augustynowicz-Kopek E (2005) Synthesis and antibacterial activity of 1H-pyrazolo[3,4-b]pyrazine and -pyridine derivatives. Il Farmaco 60:513–517
Gakhar HK, Gill GS, Multani JS (1971) Thiopegan derivatives. Part XLIX. J Indian Chem Soc 48:953–956
Ghorab MM, Ragab FA, Heiba HI, Arafa RK, El-Hossary EM (2010) In vitro anticancer screening and radio sensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety. Eur J Med Chem 45:3677–3684
Hamama WS, Gouda MA, Badr MH, Zoorob HH (2012) Synthesis, antioxidant, and antitumor evaluation of certain new N-substituted-2-amino-1,3,4-thiadiazoles. Med Chem Res. doi:10.1007/s00044-012-0336-z
Hamblin JN, Angell TDR, Ballantine SP, Cook CM, Cooper AWJ, Dawson J, Delves CJ, Jones PS, Lindwall M, Lucas FS, Mitchell CJ, Neu MY, Ranshaw LE, Solanke YE, Somers DO, Wiseman JO (2008) Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors. Bioorg Med Chem Lett 18:4237–4241
Hao Y, Xu XP, Chen T, Zhao LL, Ji ST (2012) Multicomponent approaches to 8-carboxylnaphthyl-functionalized pyrazolo[3,4-b]pyridine derivatives. Org Biomol Chem 10:724–728
Hohn H, Polacek I, Schulze E (1973) Potential antidiabetic agents. Pyrazolo[3,4-b]pyridines. J Med Chem 16:1340–1346
Iqbal R, Zareef M, Ahmed S, Zaidi JH, Arfan M, Shafique M, Al-Masoudi NA (2006) Synthesis, antimicrobial and anti-HIV activity of some novel benzenesulfonamides bearing 2,5-disubstituted-1,3,4-oxadiazole moiety. J Chin Chem Soc 53:689–696
Joshi KC, Pathak VN, Garg U (1979) Synthesis of some new fluorine-containing 5-amino-1,3-disubstituted pyrazoles and 1H-pyrazolo[3,4-b]pyridines. J Heterocycl Chem 16:1141–1145
Kumar P, Chandak N, Kaushik P, Sharma C, Kaushik D, Aneja KR, Sharma PK (2012a) Synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory agents. Med Chem Res 21:3396–3405
Kumar P, Chandak N, Nielsen P, Sharma PK (2012b) Sulfonamide bearing oligonucleotides: simple synthesis and efficient RNA recognition. Bioorg Med Chem 20:3843–3849
Leal B, Afonso IF, Rodrigues CR, Abreu PA, Garrett R, Pinheiro LCS, Azevedo AR, Borges JC, Vegi PF, Santos CCC, da Siveira FCA, Cabral LM, Frugulhetti ICPP, Bernardino AMR, Santos DO, Castro HC (2008) Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives. Bioorg Med Chem 16:8196–8204
Lin R, Connolly PJ, Lu Y, Chiu G, Li S, Yu Y, Huang S, Li X, Emanuel SL, Middleton SA, Gruninger RH, Adams M, Fuentes-Pesquera AR, Greenberger LM (2007) Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents. Bioorg Med Chem Lett 17:4297–4302
Menegatti R, Silva GMS, Zapatta-Sudo G, Raimundo JM, Sudo RT, Barreiro EJ, Fraga CAM (2006) Design, synthesis and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic activity. Bioorg Med Chem 14:632–640
Menezes CMS, Sant’ Anna CMR, Rodrigues CR, Barreiro EJ (2002) Molecular modelling of novel 1H-pyrazolo[3,4-b]pyridine derivatives designed as isosters of the antimalarial mefloquine. J Mol Struct (Theochem) 579:31–39
Misra RN, Rawlins DB, Xiao H, Shan W, Bursuker I, Kellar KA, Mulheron JG, Sack JS, Tokarski JS, Kimball SD, Webster KR (2003a) 1H-pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases. Bioorg Med Chem Lett 13:1133–1136
Misra RN, Xiao H, Rawlins DB, Shan W, Kellar KA, Mulheron JG, Sack JS, Tokarski JS, Kimball SD, Webster KR (2003b) 1H-pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-difluorophenacyl analogues. Bioorg Med Chem Lett 13:2405–2408
Numann D, Gilkes G, Kischkewitz J (1985) Vergleich der trifluormethylierungseigenschaften von(CF3)Hg, CF3I und (CF3)2te am beispiel der reaktionen mit cyclohexen, benzol und pyridine. J Fluorine Chem 30:73–87
Ojima I (ed) (2009) Fluorine in medicinal chemistry and chemical biology. Wiley, Chichester
Okeke MI, Iroegbu CU, Eze EN, Okoli AS, Esimone CO (2001) Evaluation of extracts of the roots of Landolphia owariense for antibacterial activity. J Ethnopharmacol 78:119–127
Parekh NM, Maheria KC (2012) Antituberculosis and antibacterial evaluations of some novel phenyl pyrazoline-substituted 1H-benzo[g]pyrazolo[3,4-b]quinoline-3-ylamine derivatives. Med Chem Res 21:4168–4176
Penning TD, Talley JJ, Bertneshaw SR, Carten JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, Anderson GD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY, Isakson PC (1997) Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib). J Med Chem 40:1347–1365
Purser S, Moore PR, Swallow S, Gouverneur V (2008) Fluorine in medicinal chemistry. Chem Soc Rev 37:320–330
Rezaee S, Khalaj A, Adibpour N, Saffary M (2009) Correlation between lipophilicity and antimicrobial activity of some 2-(4-substituted phenyl)-3(2H)-isothiazolones. DARU J Pharm Sci 17:256–263
Schlosser M (2006) CF3 bearing aromatics and heterocyclic building blocks. Angew Chem Int Ed 45:5432–5446
Sharma PK, Kumar S, Kumar P, Kaushik P, Kaushik D, Dhingra Y, Aneja KR (2010) Synthesis and biological evaluation of some pyrazolylpyrazolines as anti-inflammatory–antimicrobial agents. Eur J Med Chem 45:2650–2655
Sharma PK, Singh K, Kumar S, Kumar P, Dhawan SN, Lal S, Ulbrich H, Dannhardt G (2011a) Synthesis and anti-inflammatory evaluation of some pyrazolo[3,4-b]pyridines. Med Chem Res 20:239–244
Sharma PK, Chandak N, Kumar P, Sharma C, Aneja KR (2011b) Synthesis and biological evaluation of some 4-functionalized-pyrazoles as antimicrobial agents. Eur J Med Chem 46:1425–1432
Sharma PK, Chandna N, Kumar S, Kumar P, Kumar S, Kaushik P, Kaushik D (2012a) Heteroaromatic analogues of 1,5-diarylpyrazole class as anti-inflammatory agents. Med Chem Res 21:3757–3766
Sharma PK, Kumar S, Kumar P, Kaushik P, Sharma C, Kaushik D, Aneja KR (2012b) Synthesis of 1-(4-aminosulfonylphenyl)-3,5-diarylpyrazoline derivatives as potent anti-inflammatory and antimicrobial agents. Med Chem Res 21:2945–2954
Singh SK, Reddy PG, Rao KS, Lohary BB, Misra P, Rajjak SA, Rao YK, Venkateswarlu A (2004a) Polar substitutions in the benzenesulfonamide ring of celecoxib afford a potent 1,5-diarylpyrazole class of COX-2 inhibitors. Bioorg Med Chem Lett 14:499–504
Singh SP, Naithani R, Aggarwal R, Prakash O (2004b) Synthesis of some novel fluorinated pyrazolo[3,4-b]pyridines. Synth Commun 34:4359–4367
Sloop JC, Bumgardner CL, Washington G, Loehle WD, Sankar SS, Lewis AB (2006) Keto–enol and enol–enol tautomerism in trifluoromethyl-β-diketones. J Fluorine Chem 127:780–786
Soliman R (1979) Preparation and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles. J Med Chem 22:321–325
Turkmen H, Zengin G, Buyukkircali B (2011) Synthesis of sulfanilamide derivatives and investigation of in vitro inhibitory activities and antimicrobial and physical properties. Bioorg Chem 39:114–119
Witherington J, Bordas V, Gaiba A, Garton NS, Naylor A, Rawlings AD, Slingsby BP, Smith DG, Takle AK, Ward RW (2003a) 6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett 13:3055–3057
Witherington J, Bordas V, Gaiba A, Garton NS, Naylor A, Rawlings AD, Slingsby BP, Smith DG, Takle AK, Ward RW (2003b) 6-Heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett 13:3059–3062
Wu JJ, Millot G, Dandache S, Gouveia K, Xiao Y, Yelle J, Sevigny G, Dubois A, Tian B, Perron V, Herbart D, Stranix BR (2007) Novel small molecule inhibitors of HIV-1 integrase. Antivir Ther 12:S8 (abstract no. 6). 16th International HIV Drug Resistance Workshop, Barbados, 12–16 June 2007
Acknowledgments
Defence Research and Development Organization (DRDO), New Delhi is thankfully acknowledged for financial support in the form of a research project. Authors (NC and SK) are grateful to the Council of Scientific and Industrial Research (CSIR), New Delhi and University Grants Commission (UGC), New Delhi, respectively, for the award of senior research fellowships. The authors are thankful to Sophisticated Analytical Instrument Facility, Central Drug Research Institute, Lucknow for Mass spectra.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chandak, N., Kumar, S., Kumar, P. et al. Exploration of antimicrobial potential of pyrazolo[3,4-b]pyridine scaffold bearing benzenesulfonamide and trifluoromethyl moieties. Med Chem Res 22, 5490–5503 (2013). https://doi.org/10.1007/s00044-013-0544-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-013-0544-1